May 8, 2017 / 3:57 PM / in 3 months

BRIEF-Takeda says presentation of real-world analyses supporting effectiveness of Entyvio

1 Min Read

May 8 (Reuters) - Takeda Pharmaceutical Co Ltd

* Announced presentation of eight real-world analyses supporting effectiveness and safety of entyvio

* Analyses of Entyvio for treatment of adults with moderately to severely active ulcerative colitis and crohn's disease Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below